Parkinson’s Caffeine Correlation Offers Possible New Test
While there is still much to learn about Parkinson’s caffeine correlation (or about Parkinson’s in general), there is a new development.
A new study to be released in Neurology identifies caffeine levels in the blood as a potential biomarker for Parkinson’s disease, Researchers discovered people with Parkinson’s had lower levels of caffeine in their blood than people without the disease, even if they had consumed the same amount of caffeine.
Testing the level of caffeine in the blood may provide a simple way to aid the diagnosis of Parkinson’s disease, according to a study published in the January 3, 2018, online issue of Neurology.
The study found that people with Parkinson’s disease had significantly lower levels of caffeine in their blood than people without the disease, even if they consumed the same amount of caffeine.
“Previous studies have shown a link between caffeine and a lower risk of developing Parkinson’s disease, but we haven’t known much about how caffeine metabolizes within the people with the disease,” said study author Shinji Saiki, MD, PhD, of Juntendo University School of Medicine in Tokyo, Japan.
People in the study with more severe stages of the disease did not have lower levels of caffeine in the blood, suggesting that the decrease occurs from the earliest stages of the disease, according to David G. Munoz, MD, of the University of Toronto in Canada, who wrote an editorial accompanying the study.
Source: Caffeine Level in Blood May Help Diagnose Parkinson’s – Neuroscience News
Our Model
The HealthCare Too model provides for a collaborative holistic care approach to health. We look for articles and knowledge to help consumers and their care teams make holistic health decisions and also shop for the best deals in holistic health so you can find them here! We appreciate the value of surgery and pharmaceuticals but want to make more paths available for your HealthCare Too. See our model for Holistic Health for more information!
